Table 4.
1-, 3- and 5-year cumulative incidences of death among patients in the training cohort. SEER 2004–12 (n = 2247)
| Cumulative incidence of death resulting from colorectal cancer | Cumulative incidence of death resulting from other causes | |||||||
|---|---|---|---|---|---|---|---|---|
| 1-Year (%) | 3-Year (%) | 5-Year (%) | P | 1-Year (%) | 3-Year (%) | 5-Year (%) | P | |
| All | 23.04 | 54.94 | 71.27 | 2.48 | 4.75 | 6.12 | ||
| Sex | 0.741 | 0.656 | ||||||
| Female | 24.1 | 55.0 | 71.8 | 2.1 | 4.5 | 5.7 | ||
| Male | 21.9 | 54.9 | 70.7 | 2.9 | 5.0 | 6.6 | ||
| Age | <0.001 | 0.011 | ||||||
| 18–39 | 12.4 | 42.3 | 60.3 | 1.5 | 5.3 | 5.3 | ||
| 40–59 | 13.9 | 47.2 | 66.8 | 1.1 | 2.6 | 3.9 | ||
| >60 | 31.5 | 62.5 | 76.0 | 3.7 | 6.3 | 7.9 | ||
| T | <0.001 | 0.77 | ||||||
| T1 | 6.5 | 30.1 | 50.0 | 3.2 | 7.2 | 12.0 | ||
| T2 | 12.4 | 36.4 | 66.1 | 0 | 4.9 | 6.9 | ||
| T3 | 19.4 | 51.6 | 69.2 | 2.4 | 4.3 | 5.5 | ||
| T4 | 31.8 | 64.6 | 76.9 | 2.9 | 5.5 | 6.8 | ||
| N | <0.001 | 0.106 | ||||||
| N0 | 15.7 | 40.2 | 61.2 | 2.9 | 5.3 | 9.1 | ||
| N1 | 20.2 | 51.7 | 67.5 | 2.1 | 4.8 | 5.8 | ||
| N2 | 28.4 | 63.5 | 78.3 | 2.7 | 4.5 | 5.1 | ||
| M | <0.001 | 0.525 | ||||||
| M1a | 14.7 | 47.3 | 67.8 | 1.9 | 5.9 | 5.9 | ||
| M1b | 25.3 | 56.9 | 72.4 | 2.7 | 4.6 | 6.0 | ||
| CEA | <0.001 | 0.795 | ||||||
| Negative | 19.6 | 45.5 | 62.9 | 2.3 | 4.2 | 5.9 | ||
| Positive | 24.1 | 57.9 | 74.0 | 2.5 | 4.9 | 6.2 | ||
| Grade | <0.001 | 0.027 | ||||||
| Well differentiated | 13.1 | 49.5 | 65.8 | 4.0 | 4.0 | 11.8 | ||
| Moderately differentiated | 18.5 | 49.9 | 68.7 | 2.4 | 5.2 | 6.4 | ||
| Poorly differentiated | 35.9 | 68.6 | 78.6 | 2.7 | 3.9 | 4.5 | ||
| Undifferentiated; | 35.1 | 66.9 | 76.3 | 1.2 | 3.1 | 3.1 | ||
| Histology | 0.005 | 0.88 | ||||||
| Other Adenocarcinoma | 22.0 | 53.0 | 69.9 | 0.025 | 0.050 | 0.063 | ||
| Mucinous adenocarcinoma | 28.4 | 70.6 | 82.5 | 0.016 | 0.016 | 0.034 | ||
| Signet ring cell carcinoma | 52.4 | 76.9 | 86.5 | 0.057 | 0.087 | 0.087 | ||
| Race | 0.258 | 0.742 | ||||||
| White | 23.3 | 54.1 | 70.1 | 2.7 | 4.8 | 6.2 | ||
| Black | 23.7 | 62.7 | 80.3 | 2.6 | 4.7 | 5.4 | ||
| Othersa | 19.7 | 51.9 | 69.7 | 0.6 | 4.5 | 6.8 | ||
Abbreviation: SEER = Surveillance, Epidemiology and End Results.
aIncluding American Indian or Alaska Native and Asian or Pacific Islander.